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Abstract 
 
Sai Lao: Deletion of Chdh (Choline dehydrogenase) in mice does not alter brain mitosis and 
apoptosis 
(Under the direction of Dr. Steven H. Zeisel) 
 
Choline is an essential nutrient. Large amounts of choline are delivered across the 
placenta to the developing fetus, contributing to brain development and, consequently, affecting 
memory performance during adulthood. Rodent studies have described specific epigenetic 
mechanisms, whereby choline deprivation altered the neurobiology of progenitor cells, 
modifying their proliferation and survival.  Choline, via oxidation to betaine, provides one-
carbon units to the methionine cycle and further, to all methylation processes part of the 
epigenetic control. We found that the choline dehydrogenase (Chdh) gene, responsible for this 
conversion, is expressed in the brain of adult and fetal mice. By deleting the Chdh gene, we 
investigated the effects of low betaine synthesis on fetal brain development. We assessed cell 
proliferation in Chdh
+/+
 and Chdh
-/-
 fetuses at embryonic day 17 (E17) by 
immunohistochemistry. Mitosis and apoptosis were not significantly altered by fetal genotype. 
Further studies will be needed to establish if gene-specific methylation is altered between Chdh 
wildtype and knockout mice fetuses. 
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Chapter 1 - Background 
 
Introduction 
 Choline is an essential nutrient required for the proper function of nearly every cell, and 
is especially important for the developing fetus. It is a critical component of cellular membranes, 
neurotransmission, and methylation. In humans, the need for choline is highly individualized as 
functional single nucleotide polymorphisms (SNPs) in genes within the choline synthesis and 
metabolism pathways may alter dietary requirements [1, 2]. Previous human and rodent studies 
have focused on modulating maternal choline intake during pregnancy and the effect on fetal 
brain development [3-7]. However, the deletion of a key gene in choline metabolism, choline 
dehydrogenase (Chdh), in the fetus may alter brain development regardless of maternal diet and 
genotype.  
Human studies have provided mixed results on the effect of maternal dietary choline on 
measures of offspring brain development [3, 6, 7], but conclusions from rodent studies have been 
more uniform. Prenatal choline deprivation resulted in increased memory loss that persists 
throughout the lifetime when compared to choline control or choline supplementation and may 
result from potential epigenetic influences of choline [4, 5, 8-10]. Oxidation of choline by 
choline dehydrogenase generates betaine, the precursor to universal methyl donor S-
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adenosylmethionine (SAM). Dietary choline may reduce SAM pool and subsequently reduce 
availability of methylation reactions which influence gene transcription. 
As aforementioned, choline may influence brain development in numerous ways since it 
is critical to multiple processes. In this section, the importance of choline to general health, 
choline metabolism, and the epigenetic influence of choline will be discussed. 
 
Choline and Health 
 In 1998, the Institute of Medicine (IOM) officially designated choline as an essential 
nutrient. Adequate intake (AI) for choline as established by the IOM, Food and Nutrition Board 
is 550 milligram/day for adult males and 425 milligrams/day for adult females. AI for pregnant 
and lactating women is 450 mg/day and 550 mg/day, respectively [12, 13]. Choline deficiency 
has been linked to several adverse conditions, such as non-alcoholic fatty liver (NAFLD) [14], 
skeletal muscle damage [15], neural tube defects [16], and increased breast cancer risk [12]. 
These conditions can be linked to the complex roles that choline plays in important metabolic 
pathways and as a key element in cellular integrity. The need for choline starts prenatally and 
continues throughout life. 
 Liver is an important site for choline metabolism and storage, and also requires choline 
for proper function. Fatty liver develops when triglycerides accumulate in the liver and has been 
linked to choline deficiency [14]. Choline’s role in fat metabolism extends from its utilization for 
phosphatidylcholine (PC) synthesis; 70% of PC in the liver is generated from the choline 
pathway and 30% from phosphatidylethanolamine (PE) catalyzed by phophatidylethanolamine 
N-methyltransferase (PEMT). PEMT has an estrogen response element and therefore adequate 
intake levels for men and post-menopausal women are higher than premenopausal women. SNPs 
3 
 
in the hormonal regulation (estrogen response element) of PEMT may alter the endogenous 
synthesis of choline and thus require increased dietary choline, even for premenopausal women 
[17]. Phosphatidylcholine is an essential phospholipid for mammals and is necessary for 
synthesis of very-low-density lipoprotein (VLDL). Triglycerides are packaged and secreted from 
the liver in VLDLs for storage in adipose tissues or utilization [18]. Clearly, choline deficiency 
results in decreased PC synthesis resulting in decreased ability for triglyceride export and 
subsequently impair liver function. If choline deficiency persists NAFLD, cirrhosis, and hepatic 
carcinoma may develop [14]. 
 Choline deficiency in humans has also been found to increase skeletal muscle damage as 
marked by increased serum creatine phosphokinase (CPK) and more fragile myoctyes, which is a 
result of muscle cell PC depletion  [19]. Furthermore, muscle mitochondria contain a choline 
transporter, SLC44A1, which shows reduced mRNA and protein expression with choline 
deficiency. Similar to hepatocytes, choline deficient muscle cells accumulate fat [20] which may 
result from perturbed mitochondrial function and lipid oxidation [14]. 
 Neural tube defects risks were found to be the lowest in women whose intake of choline 
was above the 75
th
 percentile. Choline metabolism intersects with folate metabolism in the 
pathway for methyl-group donation (S-adenosylmethionine formation) and it is suggested that 
this may be the route by which choline affects neural tube closure [16].  
 As evidenced here, choline is needed for proper function of multiple bodily systems with 
potentially severe consequences if adequate choline supply is not met. 
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Choline Metabolism 
 Choline is a quaternary amine that can be derived from dietary sources or synthesized de 
novo from PE catalyzed by PEMT to form PC and then catabolism of PC by phospholipases and 
lysophospholipases. Foods rich in choline are eggs, milk, and animal meat. Approximately 95% 
of choline in animals is in the form of PC with the remaining as free choline, phosphocholine, 
CDP-choline, and acetylcholine. Choline metabolism occurs mainly in the liver and kidney and 
directed into three main routes: betaine, PC, or acetylcholine synthesis [18]. 
Acetylcholine, an important neurotransmitter in learning and memory function [21], is 
synthesized from choline and acetate via choline acetyltransferase, and acetylcholine esterase 
catalyzes the reaction in the reverse direction [18]; thus, allowing for choline generation from 
this neurotransmitter when needed.  
As previously mentioned, choline is mainly directed towards the formation of PC via the 
Kennedy Pathway [22]. Choline kinase phosphorylates choline to phosphocholine which is then 
converted to CDP-choline by CTP:phosphocholine cytidylyltransferase. In the final step of PC 
synthesized by CDP-choline:1,2-diacylglycerol cholinephosphotransferase. Phosphatidylcholine 
can then be incorporated into lipoproteins, membranes, sphingomyelin, phosphatidylserine, and 
bile among others.  
Betaine is an organic osmolyte necessary for normal kidney function and an important 
methyl donor for the conversion of homocysteine to methionine, which is the precursor for the 
universal methyl donor S-adenosylmethionine (SAM). Betaine is generated from choline in a 
two-step process. First, choline dehydrogenase within the inner mitochondrial membrane 
converts choline to betaine aldehyde. This is followed by the synthesis of betaine from betaine 
aldethyde within the mitochondria and cytosol by betaine aldehyde dehydrogenase (BADH). 
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Homocysteine and betaine are precursors for methionine synthesis which is catalyzed by betaine-
homocysteine methyltransferase (BHMT) [23]. SAM is generated from methionine by 
methionine adenosyltransferase (MAT) and can be utilized in transmethylation reactions [24]. 
After donating its methyl group, SAM is converted to S-adenosylhomocysteine (SAH). 
Eventually, SAH results in homocysteine and betaine is required for remethylation of 
homocysteine. 
Endogenous choline synthesis requires PE and three transmethylation reactions catalyzed 
by PEMT to form PC. Consequently, transmethylation reactions utilize SAM and the problem 
becomes increasingly apparent when choline deficiency occurs – reduced ability to produce 
betaine resulting in reduced SAM pool leading to reduced methylation reactions that control 
expression of important genes and decreased endogenous synthesis of choline, PC, betaine, and 
acetylcholine. Thus, the need for choline is increased during pregnancy due to requirements for 
proper function of maternal organs and for proper fetal development. 
During pregnancy, choline is actively transported across the placenta to the fetus [25-27]. 
Maternal choline intake during pregnancy has been shown to affect the developing fetus. Dietary 
choline deficiency during pregnancy leads to impaired memory function [28], alter fetal brain 
angiogenesis [29], decreased progenitor cell proliferation and increased apoptosis in the fetal 
brain[4], and epigenetic alterations in the brain [5, 30]. Thus, the demand for choline is 
particularly high during this critical developmental period.  
 
Choline and Epigenetics 
Epigenetics has an ever-changing definition, but it is widely accepted as the study of 
processes that change gene activity without alterations to the DNA sequence. These epigenetic 
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modifications are heritable mitotically and/or meiotically and include DNA methylation and 
chromatin modifications. DNA methylation involves addition of a methyl group (CH3) to 
cytosine, adenine, or guanine. Methylation of cytosine at CpG sites and CpG islands, CG 
dinucleotide rich regions, to from 5-methylcytosine are most widely studied due to their 
implications in carcinogenesis. If the CpG site is within the promoter of a gene, DNA 
methylation may alter the binding of transcription factors and thus prevent proper expression or 
inhibition of the gene. DNA stability and repair is also affected by methylation. Another type of 
epigenetic modification that was recently discovered is hydroxymethylation, which is the 
replacement of hydrogen by a hydroxymethyl group at the 5-position of cytosine. 
Hydroxymethylation is thought to be part of the demethylation process; therefore, methylation is 
potentially a dynamic and reversible process [31-37]. 
Choline contributes to epigenetic modifications via its role as a source of methyl-groups 
for SAM production [38], particularly homocysteine  remethylation. Diets deficient in choline 
was shown to deplete hepatic SAM concentrations [39] and induce hyper- and hypo-methylation 
[38, 40]. In a C57BL/6 mouse model, perinatal choline deficiency altered offspring global and 
gene-specific methylation patterns leading to changes in mRNA and protein expression that 
inhibits the cell cycle [5]. Data here indicate the potential role of perinatal choline nutrition 
influencing the epigenetic control of gene expression during critical developmental periods. 
Thus, if choline dehydrogenase is critical to synthesis of betaine and subsequently the generation 
of SAM, Chdh deletion could potentially result in aberrant DNA methylation patterns affecting 
organ development.  
 
 
7 
 
Hypothesis 
 Choline has complex and varied roles at different stages of development for multiple 
tissues and dietary need is different for each individual based on genetic disposition. Utilization 
of a mouse model allows close examination of the role of choline in multiple organs during 
developmental periods. With the evidence presented above, a mouse model in which Chdh has 
been deleted will be used to determine the effect of this gene on neural progenitor cell 
proliferation in fetal samples. We hypothesized that deletion of a key gene in one-carbon 
metabolism and important pathway in methyl-group donation will result in aberrant methylation 
patterns influencing gene transcription and ultimately organ development and function. 
For the current study, we studied mitosis and apoptosis of progenitor cells in the 
developing fetal brain at embryonic day 17 (E17) in a Chdh chimeric mouse model. The 
objective was to determine whether results from E17 Chdh
-/-
 fetuses are similar to offspring from 
low-choline-fed dams. The results of this investigation provide better understanding of the 
differences between Chdh
+/+
 and Chdh
-/-
 in the fetal environment and will help to develop future 
research goals in determining the role of choline dehydrogenase in methylation. 
 
  
 
 
 
 
 
 
 
Chapter 2 – Journal Manuscript 
 
Introduction 
Choline, a water-soluble essential nutrient found in foods such as eggs and animal meat, 
is involved in many biological processes including neurotransmitter and membrane biosynthesis 
and methyl-group donation [12]. In order to be used as a methyl-donor, choline must be oxidized 
to form betaine in a 2-step pathway catalyzed by choline dehydrogenase (encoded by Chdh) and 
betaine aldehyde dehydrogenase (BADH). In humans, there are functional single nucleotide 
polymorphisms (SNPs) in CHDH that decrease the formation of betaine from choline [23, 38]. 
 Studies in rodents have shown that decreased availability of choline in maternal diet 
during pregnancy resulted in diminished neurogenesis and increased neural progenitor cell 
apoptosis in the fetal hippocampus, leading to diminished hippocampal (memory) function in the 
offspring [4, 41, 42]. Previously, we suggested that the mechanism whereby maternal dietary 
choline affects fetal brain neurogenesis was epigenetically mediated. We showed that, in IMR-32 
neuroblastoma cells grown in low-choline medium, the promoter region of CDKN3 (encoding 
cyclin-dependent kinase inhibitor 3) was hypomethylated [9]. This was associated with increased 
gene expression, increased protein product of this gene (kinase-associated phosphatase; Kap) 
with resulting inhibition of the G1/S phase of the cell cycle and reduced cell proliferation. In 
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subsequent studies, using laser-capture micro-dissection (LCM), we harvested neural progenitor 
cells from the prime germinal zone of the dentate gyrus (hippocampus) of fetuses from dams fed 
a low choline diet and observed decreased gene-specific DNA methylation of the gene (Cdkn3) 
that encodes for Kap, correlating with increased expression of this protein [5].  Maternal dietary 
choline also modulated methylation of histones in fetal brain [43]. These epigenetic effects of a 
low choline diet provided a plausible explanation for the relationship between dietary choline 
and neural progenitor cell proliferation and apoptosis. 
 In order to test this hypothesis, we created a mouse in which Chdh was deleted [23].  This 
mouse cannot form betaine from choline [23] and therefore cannot use choline as a methyl-
donor.  We hypothesized that the knockout mouse would have changes in fetal brain that were 
similar to those seen when dams were fed a low choline diet - diminished neurogenesis and 
increased neural progenitor cell apoptosis in the hippocampus.  We report that this was not the 
case - neurogenesis and neural progenitor cell apoptosis in the hippocampus were not affected by 
Chdh gene deletion. 
 
Methods  
Animal models and tissue collection 
All procedures were reviewed and approved by the Institutional Animal Care and Use 
Committee (IACUC) of the University of North Carolina at Chapel Hill (Chapel Hill, NC, USA) 
and at the David H. Murdock Research Institute (Kannapolis, NC, USA). 
We previously described how the Chdh knockout mouse was created [23]. Mice were 
housed in a 12-hour light-dark cycle and temperature controlled environment. For 
immunohistochemistry (IHC) studies, male and female Chdh
+/-
 mice with mixed C57Bl/6 and 
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129 backgrounds were timed-mated. Throughout pregnancy, mice had ad libitum access to a 
defined diet (AIN-76A) containing 1.1 g/kg choline chloride (Dyets Inc., Bethlehem, PA, USA) 
and water. Dams were anesthetized with isoflurane, and fetuses collected on day E17 of 
gestation. Typical litter size for each dam is 6-8 offspring. Animal genotypes and sex of fetal 
samples were determined as previously described [23]. Fetal brains were collected as described 
previously [4], fixed in 4% paraformaldehyde overnight, paraffin embedded and then sectioned 
at 5 µm. 
For gene expression experiments, adult male Chdh wildtype mice were anesthetized with 
isoflurane and liver and brain was extracted and immediately snap-frozen in liquid nitrogen. 
Methods for liver and brain collection from fetuses has been previously described [4]. Samples 
were stored at -80°C until analysis.  
 
Chdh mRNA expression 
Choline dehydrogenase mRNA expression was analyzed to determine if the gene is 
expressed in the fetal brain and its relative expression level to adult tissues. RNeasy Protect Mini 
Kit (Cat. No. 74124, Qiagen, Venlo, Netherlands) was used following manufacturer’s protocol 
with to extract RNA from frozen liver and brain tissues of Chdh fetal and adult mice. 
Complementary DNA (cDNA) synthesis was synthesized with Applied Biosystems High 
Capacity cDNA Reverse Transcription Kit (Cat. No. 4368814, NY, USA) following 
manufacturer’s protocol in 20 uL reaction volume with an Eppendorf Mastercycler epGradient 
(Hamburg, Germany) machine. Gene expression was assessed using quantitative real-time PCR 
(qRT-PCR). Materials used were TaqMan 2X Master Mix (Cat. No. 4369016, Applied 
Biosystems, NY, USA), 20X mChdh assay (Mm00549261_m1, Applied Biosystems, NY, USA) 
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and 20X mGapdh assay (Mm99999915_g1, Applied Biosystems, NY, USA). Quantitative RT-
PCR was performed on an Eppendorf Realplex
2
 Mastercycler epGradient S running Eppendorf 
Mastercycler ep realplex 2.2 (Hamburg, Germany). Gene expression data was analyzed by the 
comparative CT method (2
-∆∆CT
)[44] with data normalized to  Gapdh and then normalized to 
adult expression values. 
 
Immunohistochemistry 
Mitosis and apoptosis were assessed in at least three alternating 5 µm sections of the 
hippocampus from each of 4-6 fetal brains. Both hemispheres were analyzed in each section. 
To assess mitosis in the fetal hippocampus, coronal sections of the embryonic day 17 
(E17) fetal brain were probed for phosphorylated histone H3, a core protein of the nucleosome 
and marker for mitosis. The immunohistochemistry protocol used has been previously described 
[4]. Rabbit anti-H3Ser10ph (Cat. No. 06-570, Millipore, MA, USA) was used as the primary 
antibody. Goat anti-rabbit Cy3 conjugated secondary antibody (Cat. No. AP132C, Millipore, 
MA, USA) and 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Cat. No. 32670, Sigma-
Aldrich, MO, USA) were used to fluorescently label the primary antibody and all nucleated cells, 
respectively. Images were acquired at the University of North Carolina at Chapel Hill 
Microscopy Services Laboratory (Chapel Hill, NC, USA) using an Olympus BX61 (Tokyo, 
Japan) upright fluorescence microscope controlled by Improvision Volocity (PerkinElmer, 
Waltham, MA, USA) acquisition software on an Apple iMAC under OS X Version 10.6.8 
(Cupertino, CA, USA). 
DNA fragmentation is a hallmark of apoptosis. The ApopTag® In Situ Apoptosis 
Fluorescein Detection Kit (Cat. No. S7111, Millipore, MA, USA), a terminal deoxynucleotidyl 
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transferase dUTP nick end labeling (TUNEL)-based assay, enzymatically labels the free 3’-OH 
end on single and double DNA strand breaks for fluorescent detection. Manufacturer’s protocol 
was followed with several modifications; xylene washes and sample rehydration was followed 
according to mitosis protocol as previously described [4]. Sections were incubated in 1x PBS-T 
overnight at 4°C following the stop/wash buffer step. Following the anti-dioxigenin conjugate 
incubation, samples were rinsed in PBS-T, then incubated in a DAPI working buffer protected 
from light, washed with PBS-T, mounted in 80% tris-buffered glycerol (pH 7.0) with No. 1 glass 
coverslip, and sealed with commercial nail polish. Images were acquired at the David H. 
Murdock Research Institute Microscopy Facility (Kannapolis, NC, USA) using a Zeiss Axio 
Imager.M1 (Oberkochen, Germany) and Zeiss AxioVision Relesase 4.8.1 (11-2009) 
(Oberkochen, Germany). 
 
Image analysis 
Images acquired for mitosis analysis were converted to JPEG format and viewed under 
Adobe Photoshop 6.0 Version 6.0.1 (San Jose, CA, USA) to manually count positive mitotic 
cells. Each positively stained H3ser10ph cell was identified as one count. Cells exiting M-phase 
of the cell cycle, visualized as two fused cells by IHC, were identified as two individual counts. 
Apoptotic cell counts were gathered manually using Zeiss AxioVision Release 4.8.1 (11-2009) 
software and each brain lobe was divided into three regions (hippocampus, neocortex, 
caudoputamen-amygdala) for analysis. For apoptosis, each fragmented cell was identified as one 
individual count. Hippocampus and neocortex ventricle length were measured with open source 
software Fiji [45] to determine major structural changes between genotype. SL was blind to the 
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genotype of the samples when counting the mitosis- and apoptosis-positive cells and measuring 
ventricle length. 
 
Statistics 
For Chdh expression differences between adult and E17 fetal samples, mitosis data, 
apoptosis data, and global DNA methylation data, Student’s t-Test (α = 0.05) assuming equal 
variances (Excel 2010, Microsoft, Redmond, WA, USA) was performed to determine 
significance between groups in each experiment. P-values less than 0.05 were considered 
statistically significant for all statistical analyses.  
 
Results 
Chdh expression 
Chdh expression in fetal liver (Figure 1A) and brain (Figure 1B) of male wildtype mice 
was significantly lower than that of the same tissues in adult male wildtype mice.  No Chdh was 
expressed in knockout mice. Results here verify that Chdh mRNA expression is present in fetal 
liver and brain. 
 
Mitosis 
Neuronal progenitor cells proliferate adjacent to the ventricle and then migrate to other 
areas of the brain. Therefore, positively labeled H3ser10ph cells were observed in close 
proximity to the ventricle in the E17 brains (Figure 2A, 2B). There was no statistical difference 
in the number of mitotic cells in the primordial hippocampal region; Chdh
+/+
 (17.1 ± 2.3 
H3ser10ph positive cells; n = 4) and Chdh
-/-
 (17.5 ± 2.6 H3ser10ph positive cells; n = 6) or in the 
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neocortical region, Chdh
+/+
 (17.0 ± 2.6 H3ser10ph positive cells; n = 4) and Chdh
-/-
 (13.1 ± 2.1 
H3ser10ph positive cells; n = 6) (Figure 2C). P-value was greater than 0.05 for both analyses. 
Ventricular length was measured and was not different between genotypes (hippocampal 
ventricular length Chdh
+/+
 1295 ± 67 µm, n =4; Chdh
-/-
 1439 ± 92 µm, n =4; neocortical 
ventricular length Chdh
+/+
 1487 ± 51 µm, n =4; Chdh
-/-
 1561 ± 93 µm, n =4; Figure 2D).  
Sample size (n) for mitosis, apoptosis, and global DNA methylation analysis represents 
the number pregnant dams from which fetal samples were collected. Several Chdh
+/+
 and Chdh
-/-
 
samples were collected from the same dam. 
 
Apoptosis 
TUNEL analysis of apoptosis indicated cell death throughout the brain. There was no 
difference in numbers of TUNEL-positive cells in any of the 3 regions studied ((hippocampus, 
neocortex, or caudoputamen-amygdala; (Figure 3A-C). In the hippocampus region,  Chdh
+/+
 and 
Chdh
-/-
 had 5.2 ± 0.4 (n = 6) vs. 4.9 ± 0.9 (n = 6) apoptotic cells, respectively. In the neocortex 
region, Chdh
+/+
 and Chdh
-/-
 had 9.3 ± 0.8 (n = 6) vs. 9.4 ± 1.7 (n = 6) apoptotic cells, 
respectively.  In the caudoputamen and amygdala (CP-A) region, Chdh
+/+
 and Chdh
-/-
 had 4.3 ± 
0.8 (n = 6) vs. 5.5 ± 0.7 (n = 6) apoptotic cells, respectively.  P-value was greater than 0.05 for 
all three analyses. 
There were no differences by genotype in ventricular length (Chdh
+/+
 1,417 ± 96 µm (n = 
6) versus Chdh
-/-
 1,464 ± 72 µm(n = 6)) or neocortical ventricular length (Chdh
+/+
 1,641 ± 97 µm 
(n = 6) versus Chdh
-/ 
1,615 ± 78 µm (n = 6)) (Figure 3D). 
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For mitosis and apoptosis data, Means and 95% confidence intervals for KO minus WT 
were computed for each measure and region from the mitosis and apoptosis data (Supplemental 
Table 1). 
 
Discussion 
Deletion of Chdh in mice did not significantly alter the founder population of progenitor 
cells during brain development when compared to Chdh wildtype in brain on day E17.  In 
addition, in wildtype mice, we found that expression of Chdh in brain and liver was much lower 
in fetuses than in adult mice.   
As discussed earlier, a potential epigenetic mechanism for the effects of choline on fetal 
brain neurogenesis and apoptosis has been suggested [5, 9, 43].  Because choline must be 
converted into betaine before it can serve as a methyl-donor [48], we expected that the effect of 
deleting this gene on fetal brain development would be similar to the effect of feeding a low 
choline diet to dams – decreased mitosis and increased apoptosis of neural progenitor cells in the 
developing E17 hippocampus. In future studies we plan to measure epigenetic marks on genes 
regulating cell cycle (i.e., Cdkn3) and histones with increased sample size and expect to see no 
difference by fetal genotype. 
The Chdh mouse does not make betaine, and therefore accumulates more choline and the 
phosphorylated products of choline, including phosphatidylcholine, in tissues [23].  If the 
underlying mechanism explaining the effects of dietary choline on fetal brain neurogenesis and 
apoptosis involves the accumulation of choline or phosphatidylcholine rather than epigenetic 
marks, then we would expect the effect of deleting this gene on fetal brain development to be 
similar to the effect of feeding a high choline diet to dams – increased mitosis and increased 
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apoptosis of neural progenitor cells in the developing E17 hippocampus.  This was not the case. 
Analysis of Cdkn3 methylation and KAP in Chdh
-/-
 fetal samples will provide a direct 
comparison against the choline deficient model. 
Several functional SNPs in the human CHDH gene have been identified that may alter 
choline metabolism [1, 53]. Studying a knockout mouse model provides insight into the 
importance of the gene in multiple body systems, particularly the fetal brain in the present study.  
The current study has limitations. First, the mice model used is on a mixed 129/C57BL6 
background. One study found inter-strain differences in mouse liver pathology when placed on a 
choline- and folate-deficient diet; C57BL/6J and 129S1/SvImJ were among the mouse strains 
used in the study [54]. Thus, it is possible that the mixed background of the mouse model may 
potentially mask differences.  Secondly, we did not directly measure DNA and histone 
methylation and therefore cannot be sure that deletion of Chdh does not alter epigenetic marks, 
especially on genes critical to cell cycle regulation. Finally, we use mothers that were 
heterozygous for Chdh, and these mothers might have supplied betaine to the fetal brain. In 
future studies we plan to determine whether fetuses from Chdh
-/-
 mothers have different brain 
phenotype than do fetuses derived from Chdh
+/-
 dams. 
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Figures 
 
 
 
Figure 1. Chdh Expression 
A) Chdh
 
expression in fetal (n = 12) liver is 54.2% of adult (n = 14) liver. B) Chdh expression in 
fetal (n = 12) brain is 25.8% of adult (n = 12) brain. Error bars are standard error; Results are 
normalized to housekeeping gene Gapdh and then normalized to adult samples calculated with 
the comparative CT (2
-ΔΔCT
) statistical method. *P<0.05. 
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Figure 2. Mitosis in Chdh
+/+
 and Chdh
-/-
 fetal brains 
Coronal brain sections from E17 fetuses were analyzed by immunohistochemistry for 
H3ser10ph, a marker of mitosis. A) Mitotic cells in the hippocampus for Chdh
+/+
 (n = 4) and 
Chdh
-/-
 (n = 6) are 17.062±2.302 and 17.455±2.644, respectively. In the neocortex, Chdh
+/+
 (n = 
4) is 16.964±2.605 and Chdh
-/-
 (n = 6) is 13.078±2.070. Student t-Test (α=0.05) indicates no 
statistical difference. P>0.05. Data are shown as (mean ± standard error). Error bars are standard 
error. B) Hippocampal ventricle length is Chdh
+/+
 (n = 4) 811.561±42.156 and Chdh
-/-
 (n = 6) 
902.039±57.644. P>0.05. Neocortex ventricle length is Chdh
+/+
 (n = 4) 931.557±31.922 and 
Chdh
-/-
 (n = 6) 978.462±58.554. P>0.05. Data are shown as (mean ± standard error). Error bars 
are standard error. C) Immunohistochemistry stained coronal section of fetal E17 brain. 
Proliferating cells are red in color and visualized adjacent to the ventricle; these cells are distinct 
from endogenous vasculature (green) and are overlaid on nucleated cells (blue). D) Enlarged 
image to show H3ser10ph labeled cells (red), nucleated cells (blue), and endogenously 
fluorescent vasculature (green). 
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Figure 3. Apoptosis in Chdh
+/+
 and Chdh
-/-
 fetal brains 
Coronal sections from brains of E17 fetuses were analyzed by immunohistochemistry for 
markers of apoptosis using TUNEL (terminal deoxynucleotidyl transferase dUTP nick end 
labeling). A) Average apoptotic cell count in Chdh
+/+
 (n = 6, dark grey bars) and Chdh
-/-
 (n = 6, 
white bars) fetal brain sections. In hippocampus, neocortex, and caudoputamen-amygdala (CP-
A) regions, positive apoptotic cell counts are 5.16 ± 0.35 vs. 4.91 ± 0.90, 9.27 ± 0.85 vs. 9.35 ± 
1.67, and 4.30 ± 0.78 vs. 5.53 ± 0.70, respectively, for Chdh
+/+
 vs. Chdh
-/-. Student’s t-Test (α = 
0.05) shows no difference between genotype. P>0.05 for all comparisons. Data are shown as 
(mean ± standard error).  Error bars are standard error. B) The ventricular zone length on the 
hippocampal (1417.07 ± 96.34 µm vs. 1464.00 ± 72.14 µm) and neocortex (1641.26 ± 97.31 µm 
vs. 1615.34 ± 78.35 µm) were measured Chdh
+/+
 and Chdh
-/-, respectively. Student’s t-Test (α = 
0.05) shows no difference. Data are shown as (mean ± standard error). Error bars are standard 
error. C) Coronal section of brain lobe with ventricular zone. Positively labeled fragmented DNA 
are bright green in color. Nucleated cells are blue in color (DAPI) and endogenously fluorescent 
blood vessels are yellow, a mix of green and red. D) Positively labeled DNA fragments (white 
arrows) are shown in the enlarged image. 
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Supplemental data 
 
Supplemental Table 1. Difference between KO and WT for each measure along with the 95% 
confidence interval 
Measure Region P-value Mean 95% CI of KO-WT 
Mitosis Hippocampus 0.92 0.4 (-8.4, 9.1) 
Mitosis Neocortex 0.27 -3.9 (-11,5 ,   3.7) 
Mitosis Hippocampus Length 0.29 90.5 (-92.6 , 273.5) 
Mitosis Neocortex Length 0.56 46.9 (-131.6, 225.4) 
Apoptosis Hippocampus 0.93 -0.1 (  -2.3,   2.1) 
Apoptosis Neocortex 0.73 0.7 (  -3.7,   5.1) 
Apoptosis CP-A 0.22 1.5 (  -1.0,   4.0) 
Apoptosis Hippocampus Length 0.47 89.3 (-177.6, 356.2) 
Apoptosis Neocortex Length 0.90 15.3 (-256.5, 287.0) 
Means and 95% confidence intervals for KO minus WT were computed for each measure and 
region from the mitosis and apoptosis data. 
 
 
Region-specific Chdh expression in adult brain 
Animal model and sample collection 
Samples for region-specific Chdh expression were collected from C57BL/6J mice. Brains 
were dissected into two hemispheres. One hemisphere was immediately clamped and snap-
frozen in liquid nitrogen and was used to determine global Chdh expression.. The other 
hemisphere was dissected by brain region in chilled 1X phosphate buffered saline with 0.1% 
Tween-20 (PBS-T) solution under a dissecting microscope, each dissected region was placed in a 
microfuge tube, and then snap-frozen in liquid nitrogen. The following regions of brain were 
dissected and analyze for Chdh gene expression: olfactory bulbs, interbrain (also known as 
diencephalon, containing the thalamus, hypothalamus, subthalamus, epithalamus), isocortex FO 
(frontal pole and orbital cortex), isocortex SR (containing somatomotor and retrosplenial cortical 
areas), dentate gyrus region of hippocampus and cerebellum 
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Methods 
RNA was extracted from frozen brain regions with RNeasy Protect Mini Kit (50) (Cat. 
No. 74124, Qiagen, Venlo, Netherlands) following manufacturer’s protocol. Complementary 
DNA was synthesized with Bio-Rad iScript™ Reverse Transcription Supermix (Cat. No. 170-
8840, Hercules, CA, USA) following manufacturer’s protocol using an Eppendorf Mastercycler 
epGradient (Hamburg, Germany) machine. Gene expression was assessed using quantitative 
real-time PCR (q-PCR). Materials used were Bio-Rad SsoFast™ Probes Supermix (Cat. No. 
172-5230, Hercules, CA, USA), Applied Biosystems 20X mChdh assay (Mm00549261_m1), 
and 20X mGapdh assay (Mm99999915_g1, Applied Biosystems, NY, USA). Quantitative RT-
PCR was performed on an Eppendorf Realplex
2
 Mastercycler epGradient S running Eppendorf 
Mastercycler ep realplex 2.2 (Hamburg, Germany). The whole brain samples were used to 
generate a standard curve with each qRT-PCR.  
Data was normalized to Gapdh housekeeping gene for each brain region of each 
individual specimen were calculated following the Relative Standard Curve Method in the 
Applied Biosystems Guide to Performing Relative Quantitation of Gene Expression Using Real-
Time Quantitative PCR
1
. Region-specific Chdh expression, statistical analysis was performed 
with REST 2009 software [46, 47]. A repeated measures ANOVA was used to compare the 
means of all six regions simultaneously and test for an overall difference. No significance was 
detected (P = 0.18).  
 
Discussion 
Since Chdh deletion resulted in no differences in fetal mitosis apoptosis we further 
questioned the role of choline in the more mature, complex adult brain. Neurogenesis begins 
                                                          
1
 www.cf.gu.se/digitalAssets/1125/1125331_ABI_-_Guide_Relative_Quantification_using_realtime_PCR.pdf 
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prenatally and continues throughout the adult life  with limited neuron formation in the dentate 
gyrus postnatally [49]. Chdh deletion could prove to be more influential in adult neurogenesis 
because of the increased Chdh expression and activity in adult brain samples. Differential Chdh 
expression in different brain regions in the adult animal potentially illustrates the importance of 
betaine to the function to those areas. To determine if Chdh shows region-specific expression in 
the brain, adult brains of C57BL/6J mice (n = 4) approximately three months old were harvested 
and analyzed. ANOVA analysis showed no overall statistical difference across all six regions, 
but there seems to be a trend with lower Chdh expression in the dentate gyrus. This is pilot data 
and requires increased sample size for any definitive conclusions. 
 
 
 
Supplemental Figure 1. Region-specific Chdh expression in adult mice brain 
Brains from adult C57BL/6J animals (n = 4) were analyzed for region-specific expression of 
Chdh. Pairwise comparisons of normalized Chdh expression to Gapdh expression show 
significant difference between cerebellum and dentate gyrus (1.3 ± 0.5 vs. 0.5 ± 0.1, *P=0.02). 
Data are shown as (mean ± standard error).  
 
 
 
 
 
 
 
Chapter 3 – Conclusions 
Conclusions 
The role of choline as an essential nutrient has only been recently identified, and it has 
been recognized that the recommended AI for choline is different for different populations. The 
need for choline is modulated by a variety of factors, such as age, gender, pregnancy, and genetic 
SNPs. Research has shown that choline is important for prenatal development, but the role of 
fetal choline metabolism has yet to be established. More importantly, does deletion of a key gene 
in choline metabolism, Chdh, in the fetus effect measurements of prenatal brain development 
even if the mother is supplied adequate amounts of dietary choline? 
In this study we focused on identifying changes in progenitor cell proliferation between 
Chdh
+/+
 and Chdh
-/-
 fetuses harvested at E17 from Chdh
+/-
 mating pairs with prenatal diets 
adequate in choline. We did not observe any significant changes in markers of mitosis and 
apoptosis between the wildtype and knockout Chdh fetal genotypes. In this section, we focus on 
more in-depth discussion of the study results, limitations, and suggestions for future studies. 
 
Choline, Mitosis, and Apoptosis 
 We showed that Chdh deletion did not result in changes in mitosis as measured by 
phosphorylated histone-3 (phospho-histone H3), a marker of mitosis that is located within the 
24 
 
nucleosome and critical for chromatin condensation maintenance during mitosis. This IHC 
method also enables visualization of different stages of mitosis based on cell shape and color 
intesnity.  Mitotic cell counts along the hippocampal and neocortical ventricular zone of the fetal 
brain did not reveal any significant differences in progenitor cell proliferation between Chdh
+/+
 
and Chdh
-/-
 fetuses.  
Apoptosis, as measured by fluorescent TUNEL IHC, also revealed no difference between 
number of apoptotic cells in Chdh
+/+
 and Chdh
-/-
 fetuses. The TUNEL assay enzymatically labels 
fragmented ends of single and double stranded DNA allowing for fluorescent identification. In 
the beginning stages of apoptosis, the cell shrink, chromatin condense, and DNA fragmentation 
occurs. This is followed by membrane blebbing and nucleus fragmentation. In the final stages of 
apoptosis, the cell fragments in to apoptotic bodies and subsequently consumed by 
phagocytes[55]. TUNEL IHC is able to capture apoptosis at these different stages, resulting in 
clusters (early apoptosis) of fluorescent fragments or isolated fragments as they break off from 
the intact cell (late apoptosis).  
 Choline is transported across the fetus and maternal plasma betaine has been shown to be 
positively associated with fetal plasma betaine [56]; thus, it is likely that choline and betaine can 
be supplied by the mother to the fetus. The results shown in Chapter 2 may reflect the fact that 
pregnant dams were on a diet sufficient in choline, and therefore the fetal environment was not 
low in choline or choline metabolites. Although the Chdh
-/-
 fetal brains may lack Chdh and the 
ability to metabolize choline, choline metabolites were readily supplied by the mother resulting 
in normal brain development. Dietary studies restricting maternal choline during pregnancy 
resulted in reduced mitosis, increased apoptosis, and methylation reflected the maternal diet and 
subsequently sources of choline metabolites, such as betaine and PC. Disruptions in betaine 
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supply affect the availability of SAM, the universal methyl donor, leading to aberrant 
methylation patterns subsequently affect progenitor cell proliferation. Alterations in brain 
development during critical periods may greatly affect brain function in later life. 
 
Chdh Expression 
Fetal mouse brains showed significantly reduced Chdh expression compared to adults. A 
study in a rat model showed that Chdh activity in the liver of the progeny does not substantially 
increased until well after birth and weaning. Clow et al. (2008) study demonstrated that liver 
Chdh activity steadily increased after birth and plateaued around 35-42 days post-birth. Kidney 
Chdh also gradually increased after birth. Choline dehydrogenase activity was not measured in 
the brain [57]. Thus, it can be speculated that much of the choline and betaine found in fetal 
tissues is a result of maternal diet and not endogenous synthesis by the fetus. 
 
Limitations 
 Aside from the limitations presented in the discussion section of Chapter 2, there are 
several others to note. First, the effect of maternal diet was not assessed. The fetus relies heavily 
on the mother for its nutrition, and thus fetal development may reflect the mother’s ability to 
metabolize such nutrients as choline. SNPs (in humans) or gene deletion (in rodent models) of 
the pregnant mothers may alter nutrient availability. For instance, perturbed choline metabolism 
in the mother may result in less betaine, SAM, and PC for the fetus leading to altered 
programming in organ development. Additionally, we did not provide measures of gene-specific 
DNA methylation, particularly for genes that control cell proliferation. Assessment of DNA 
methylation patterns, in addition to the present data, will enable mechanistic hypotheses of 
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choline dehydrogenase and epigenetic reprogramming. Last, we only analyzed progenitor cell 
proliferation in the fetal brain. The brain consists of multiple cell types (i.e., astrocytes, 
ogliodendrocytes) that contribute to brain development. Astrocytes are the most abundant cell 
type in the mammalian brain and contribute to structure and formation of the blood-brain barrier. 
Additionally, astrocytogenesis is influenced by epigenetic mechanisms [58]. It is also 
hypothesized that astrocytes regulate energy supply for neurons, and thus survival [59]. 
 
Future Studies 
Results from the current study generate several questions that could prompt further studies. Here 
I briefly propose future studies to address these questions, particularly the role of methylation 
and epigenetic regulation on progenitor cell proliferation. 
Proposed Study 1 
 The current study will have to be replicated before any subsequent studies. This will 
confirm the findings herein and provide framework for further projects. Following the same 
study design, Chdh
+/+
 and Chdh
-/-
 fetuses will be harvested from Chdh
+/-
 mating pairs fed AIN-
76A with 1.1g/kg choline chloride. Fetal brains will be fixed for immunohistochemistry analysis 
of mitosis and apoptosis as described in Chapter 2. In addition to TUNEL analysis of apoptosis, 
there will be double staining of activated caspase-3 as previously described [4]. Double staining 
will better identify cells undergoing apoptosis. If results from this proposed study confirms the 
current study, it will increase sample size and provide sufficient evidence for further studies.. 
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Proposed Study 2 
 Epigenetic regulation has been implicated in choline deficient models and this proposed 
study will determine if differential DNA methylation is present in Chdh
-/-
 fetuses compared to 
Chdh
+/+
 fetuses. Chdh
+/-
 mating pairs will be maintained on diet AIN-76A with 1.1g/kg choline 
chloride to determine the role of the Chdh gene on DNA methylation. Fetal brains harvested 
from Chdh
+/+
 and Chdh
-/-
 will be fixed, sectioned at 5 µm, and mounted on special membrane 
slides for laser-capture micro-dissection (LCM) of Ammon’s horn ventricular and subventricular 
zones and the dentate gyrus for bisulfite modification and pyrosequencing. One gene of interest 
in this study is Cdkn3, an important regulatory gene in mitosis, particularly the G1/S-phase 
transition[60]. DNA methylation changes between fetal genotypes will validate (or counter) 
results seen in choline deficiency during pregnancy. Global DNA methylation and Kap protein 
expression will be determine by immunohistochemistry. Methods for these analyses have been 
previously described [5]. 
 Results here combined with those in the current study and Proposed Study 1 will help to 
elucidate the impact of fetal Chdh deletion on brain development. 
 
Proposed Study 3 
 Maternal diet has been shown to influence mitosis, apoptosis, and DNA methylation. To 
elucidate the interaction of the gene Chdh and diet, it would be of interest to assess progenitor 
cell proliferation, apoptosis, and methylation in E17 brains of Chdh
-/-
 fetuses from Chdh
+/-
 dams 
under normal and low dietary choline during pregnancy. Methylation pattern of genes that 
regulate cell cycle cyclin-dependent kinase inhibitors proteins, Kap, p15Ink4B, and p27Kip1 will 
be assessed. Behavioral tests in the adult animals under these in-utero conditions will help to 
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determine memory function as a result of maternal diet and gene deletion. Comparisons made 
between the fetal groups will determine the role of maternal diet during critical developmental 
window for the brain, even if an important gene in choline metabolism is deleted.   
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